Cargando…
Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers
Dynamic changes of the peripheral T cell receptor (TCR) and soluble receptors and ligands (sRLs) have the potential to be used as biomarkers to monitor the evolution of the immune system in tumor patients undergoing immunotherapy. These functional biomarkers could be used to predict immune response...
Autores principales: | Li, Ye, Wang, Jiaqian, Wu, Liangliang, Li, Xiaoting, Zhang, Xiaoyun, Zhang, Guoqing, Xu, Shengqiang, Sun, Shengjie, Jiao, Shunchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216394/ https://www.ncbi.nlm.nih.gov/pubmed/34163469 http://dx.doi.org/10.3389/fimmu.2021.649343 |
Ejemplares similares
-
Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023) -
Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
por: Riva, Antonio
Publicado: (2023) -
Storm of soluble immune checkpoints associated with disease severity of COVID-19
por: Kong, Yaxian, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
por: Chen, Xi, et al.
Publicado: (2022) -
Soluble immune checkpoints in cancer: production, function and biological significance
por: Gu, Daqian, et al.
Publicado: (2018)